According to statistics, the incidence of female patients in the United States is 2.7%-6.53%, that of female patients in Japan is about 3-4/100,000, and that of female patients in Europe is about 18/100,000, among which the incidence rate of female patients is about 5 times that of male patients, and the data shows an increasing trend year by year [ 2 ].
← all excerpts
Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome.
1
—
—